Skip to main content
. Author manuscript; available in PMC: 2016 Nov 28.
Published in final edited form as: Oncogene. 2016 May 2;35(47):6087–6095. doi: 10.1038/onc.2016.146

Figure 3. High SALL4 expression level was correlated with complex karyotype in primary MDS patient samples.

Figure 3

(a) In an AML cohort of 542 patients (GSE13159) analyzed by microarray, the expression of SALL4 in AML patients with complex karyotype was significantly higher (p=0.0186) than that in MDS patients with normal karyotype. (b) In a cohort of 55 MDS patients analyzed by qRT-PCR, SALL4 in MDS patients with complex karyotype was significantly higher (p<0.001) than that in MDS patients with normal karyotype. (c) Representative SALL4 protein expression in MDS patient with complex karyotype (ii) was higher than that in MDS patient with normal karyotype (i), analyzed by IHC.